Comparative gene expression profiling analysis of lymphoblastoid cells reveals neuron-specific enolase gene (ENO2) as a susceptibility gene of heroin dependence

Addiction Biology

Volumn 19, Issue 1, 2014, Pages 102-110

  Liao, Ding Lieh ^a   Cheng, Min Chih ^b   Lai, Chih Hao ^c   Tsai, Hui Ju ^c   Chen, Chia Hsiang ^c,d,e  

^a Bali Psychiatric Center   (Taiwan)

^b YULI VETERANS HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Addiction; ENO2; gene expression; genetics; heroin; microarray

Indexed keywords

NEURON SPECIFIC ENOLASE;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME BLOOD LEVEL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE IDENTIFICATION; GENE ONTOLOGY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; WESTERN BLOTTING;

ADDICTION; ENO2; GENE EXPRESSION; GENETICS; HEROIN; MICROARRAY;

BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL LINE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEMOGLOBINS; HEROIN DEPENDENCE; HUMANS; LYMPHOCYTES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPYRUVATE HYDRATASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TAIWAN;

EID: 84890807285     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00390.x     Document Type: Article

References (36)

1. Baron CA, Liu SY, Hicks C, Gregg JP, (2006) Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J Autism Dev Disord 36: 973-982.
2. Beaudeux JL, Leger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ, (2000) Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 46: 989-990.
3. Cho WC, (2007) Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother 61: 515-519.
4. Deckmann M, Mamillapalli R, Schechtman L, Shinitzky M, (2002) A conformational epitope which detects autoantibodies from schizophrenic patients. Clin Chim Acta 322: 91-98.
5. Felder B, Radlwimmer B, Benner A, Mincheva A, Todt G, Beyer KS, Schuster C, Bolte S, Schmotzer G, Klauck SM, Poustka F, Lichter P, Poustka A, (2009) FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome. Am J Med Genet A 149A: 952-959.
6. Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, Verlaan DJ, Le J, Koka V, Lam KC, Gagne V, Dias J, Hoberman R, Montpetit A, Joly MM, Harvey EJ, Sinnett D, Beaulieu P, Hamon R, Graziani A, Dewar K, Harmsen E, Majewski J, Goring HH, Naumova AK, Blanchette M, Gunderson KL, Pastinen T, (2009) Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet 41: 1216-1222.
7. Goldman D, Oroszi G, Ducci F, (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6: 521-532.
8. Hayashi A, Kasahara T, Kametani M, Toyota T, Yoshikawa T, Kato T, (2009) Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol 12: 33-43.
9. Huang CH, Chen ML, Tsai YL, Tsai MT, Chen CH, (2004) Elevated adrenomedullin mRNA in lymphoblastoid cells from schizophrenic patients. Neuroreport 15: 1443-1446.
10. Iwamoto K, Bundo M, Washizuka S, Kakiuchi C, Kato T, (2004a) Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet 49: 227-231.
11. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T, (2004b) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9: 406-416.
12. Kovesdi E, Luckl J, Bukovics P, Farkas O, Pal J, Czeiter E, Szellar D, Doczi T, Komoly S, Buki A, (2010) Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir (Wien) 152: 1-17.
13. Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA, (2005) Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57: 1-26.
14. Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E, (2009) Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9: 17.
15. Martins-de-Souza D, Schmitt A, Roder R, Lebar M, Schneider-Axmann T, Falkai P, Turck CW, (2010) Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. J Psychiatr Res 44: 989-991.
16. Monks SA, Leonardson A, Zhu H, Cundiff P, Pietrusiak P, Edwards S, Phillips JW, Sachs A, Schadt EE, (2004) Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 75: 1094-1105.
17. Olsen L, Hansen T, Jakobsen KD, Djurovic S, Melle I, Agartz I, Hall H, Ullum H, Timm S, Wang AG, Jonsson EG, Andreassen OA, Werge T, (2008) The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet 9: 39.
18. Pancholi V, (2001) Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58: 902-920.
19. Pastinen T, Ge B, Hudson TJ, (2006) Influence of human genome polymorphism on gene expression. Hum Mol Genet 15 (Spec No 1): R9-16.
20. Philibert RA, Crowe R, Ryu GY, Yoon JG, Secrest D, Sandhu H, Madan A, (2007) Transcriptional profiling of lymphoblast lines from subjects with panic disorder. Am J Med Genet B Neuropsychiatr Genet 144B: 674-682.
21. Purcell S, Cherny SS, Sham PC, (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150.
22. Ramont L, Thoannes H, Volondat A, Chastang F, Millet MC, Maquart FX, (2005) Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 43: 1215-1217.
23. Sandler SJ, Figaji AA, Adelson PD, (2010) Clinical applications of biomarkers in pediatric traumatic brain injury. Childs Nerv Syst 26: 205-213.
24. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW, (1996) Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93: 10614-10619.
25. Shi YY, He L, (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15: 97-98.
26. Spivak B, Schechtman M, Blumensohn R, Schonherz-Pine Y, Yoran-Hegesh R, Deckmann M, Mayer R, Weizman A, Shinitzky M, (2009a) Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients-part I: young subjects. Neuropsychobiology 60: 44-48.
27. Spivak B, Schechtman M, Schonherz-Pine Y, Blumensohn R, Mostovoy S, Amital D, Deckmann M, Weizman A, Shinitzky M, (2009b) Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients-part II: adult subjects. Neuropsychobiology 60: 49-54.
28. Sullivan PF, Fan C, Perou CM, (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B: 261-268.
29. Sung HJ, Cho JY, (2008) Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41: 615-625.
30. Tannu N, Mash DC, Hemby SE, (2007) Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry 12: 55-73.
31. Uhl GR, Drgon T, Johnson C, Fatusin OO, Liu QR, Contoreggi C, Li CY, Buck K, Crabbe J, (2008) 'Higher order' addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem Pharmacol 75: 98-111.
32. Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB, (2003) Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav Rev 27: 507-515.
33. Verfaillie CJ, Delanghe JR, (2010) Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin Chem Lab Med 48: 891-892.
34. Washizuka S, Kakiuchi C, Mori K, Tajima O, Akiyama T, Kato T, (2005) Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder. Bipolar Disord 7: 146-152.
35. Yoon IS, Li PP, Siu KP, Kennedy JL, Cooke RG, Parikh SV, Warsh JJ, (2001a) Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry 6: 678-683.
36. Yoon IS, Li PP, Siu KP, Kennedy JL, Macciardi F, Cooke RG, Parikh SV, Warsh JJ, (2001b) Altered TRPC7 gene expression in bipolar-I disorder. Biol Psychiatry 50: 620-626.